Sichenzia Ross Ference Kesner LLP Represents AYTU Bioscience, Inc., in $12 Million Public Offering

Press Release – New York, NY – March 6, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented AYTU Bioscience, Inc. (NASDAQ: AYTU) in a $12 million public offering of Class A Units, comprising common stock and warrants and Class B Units comprising Series B Preferred Stock and Warrants. A total of 19,520,000 Class A Units were sold at a price of $0.45 per unit and 3,216 Class B Units were sold at a price of $1,000 per unit.  The warrants are exercisable at a price of $0.54 per share for a term of 5 years. Joseph Gunnar & Co. acted as the Sole Book Running Managing Underwriter and Fordham Financial Management, Inc. acted as the Lead Managing Underwriter.

AYTU is a specialty Life Sciences Company focused on global commercialization of novel products in the field of urology. The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Counsel, Jeff Cahlon.

• Author
• Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

• Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock - December 6, 2019
• Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article - December 6, 2019
• Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement - December 2, 2019